Peptide of the Week: What Happened to Peptide Sciences? Industry Updates, & The Future of Peptides Peptide of the Week https://peptideoftheweekpod.com/episodes/peptide-of-the-week-what-happened-to-peptide-sciences-industry-updates-the-futur/transcript We are not doctors. The content on this site is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Any compounds discussed may be intended for research purposes only. Use at your own risk. Amounts, timing and cycle lengths below are reported as the named speaker described them. Nothing here is a protocol to follow. --- 0:00 Speaker 0: Chronic migraine: 15 or more headache days a month, each lasting 4 hours or more, can make me feel like a spectator in my own life. Botox, onabotulinum 0:08 Speaker 2: toxin A, prevents headaches in adults with chronic migraine. It's not for those with 14 or fewer headache days a month. It's the number 1 prescribed branded chronic migraine preventive treatment. Prescription Botox is injected by your doctor. Effects of Botox may spread hours to weeks after injection, causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems, or muscle weakness can be signs of a life threatening condition. Patients with these conditions before injection are at highest risk. Side effects may include allergic reactions, neck and injection site pain, fatigue, and headache. Allergic reactions can include rash, welts, asthma symptoms, and dizziness. Don't receive Botox if there's a skin infection. Tell your doctor your medical history, muscle or nerve conditions, including ALS Lou Gehrig's disease, myasthenia gravis or Lambert Eaton syndrome, and medications, including botulinum toxins, as these may increase the risk of serious side effects. Why wait? Ask your doctor, visit botoxchronicmigraine.com, 0:57 Speaker 0: or call one-eight hundred-44Botox 0:59 Speaker 1: to learn more. Propel Fitness Water with Gatorade Electrolytes, 1:03 Speaker 1: 0 Sugar, and Vitamins. Propel hydrates better than water to help you get the most out of your workout and get back to your best self. What propels you? Propel with Gatorade Electrolytes. 1:24 Speaker 2: Welcome back to the Pep Tide of the Week Podcast. I'm your host, JD Denham across the way, my buddy, my pal, my business partner, my friend, 1:33 Speaker 2: William Teahawks. What's up, dude? What's up, man? It's Friday. Happy Friday. It is Friday. The time is flying, and today is a special day. 1:42 Speaker 2: We have a good friend of ours. We like to call him rather, but a good friend of ours. He's been on the show numerous times, 1:50 Speaker 2: and we bring him on when we wanna get the lowdown of what's going on on the streets of Peptides. 1:55 Speaker 2: So you've seen him numerous times if you've been following our podcast in any form for the last year or so. 2:02 Speaker 2: Paul Bactiar, he is a keynote speaker at multiple peptide conferences. I like to call him the peptide Jedi. 2:09 Speaker 4: But welcome to the show, my brother. Thank you always, my brothers. I appreciate you both and always appreciate the work that you're doing. Thanks again for inviting me on. Always appreciate being here. Yeah, man. Paul just said, if the world's gonna end, that he's gonna come to us True story. For survival. 2:25 Speaker 4: Absolutely. When 2:26 Speaker 4: it all goes down, end of the world, where do you wanna be shoulder to shoulder? And I go, there's nobody better than these 2 gents right here. 2:33 Speaker 2: That's it, baby. As iron sharpens iron, they say. That's right. I love it. I love it. So really quickly, man, how's life? How have you been, man? We, we all are busy. We catch up from time to time, but, just how's life in general, man? How how are things? Things have been good, man. It's been a blessing to be busy. Recently, 2:51 Speaker 4: took on a role of president of telehealth operations for a large medical manufacturer. 2:57 Speaker 4: In addition to that, still doing all my training, my education. I'll be speaking 3:02 Speaker 4: at the cell surgical network conference down there in your guys' neck of the woods in Manhattan Beach, 3:08 Speaker 4: coming up next month. So excited for that. Talking on peptides, things that we all know and love. 3:13 Speaker 2: Yeah, it's funny, man. I was thinking, I was thinking as we were kind of getting ready for this, that 3:17 Speaker 2: we're just 3 dorks that like to talk about peptides and compounds. 3:21 Speaker 2: We could sit here for hours and talking about them for over and over again. It's like, it's cool that we get to sit down and now it's just recorded because these are the conversations we have at dinner. Yeah. 3:34 Speaker 2: It's really that simple. Like, this is the stuff we talk about when we're hanging out anyway. It's 3:39 Speaker 3: easy. And it's the way that we have learned, right? It's like by asking questions and talking to people who also know, right? Like people ask me all the time, like, how do I, what do I do in the gym? Right? And like, 3:50 Speaker 3: how do I get in shape? Like, okay. That's not really a question that you can ask somebody to answer. Right? But I guess 1 of part of that answer is like, go to the gym and watch 4:00 Speaker 3: people who are better than you. Yep. And 4:02 Speaker 3: ask them questions. You know what mean? Like just go watch what exercises they are doing. They're doing something right, obviously. So 4:10 Speaker 3: basically surround yourself with people who know better than you or 4:13 Speaker 3: know different than you. 4:15 Speaker 3: Ask questions instead of guessing and your knowledge and you'll just get better. Basically. That's great advice as I like Yeah, 4:24 Speaker 2: man. Well, 4:25 Speaker 2: cool man. Welcome to the show. It is always a pleasure to talk with you and, 4:31 Speaker 2: you know, we bring you on when we wanna hear kind of the lowdown of what's going on on the streets. The peptide industry is 4:38 Speaker 2: always a little shaky, always a little gray, always 4:41 Speaker 2: needing to bob and weave around certain things. And the last time us 3 got together was 4:47 Speaker 2: at the end of December where there was a lot of chitter chatter of a lot of stuff going down on the streets where 4:53 Speaker 2: Red or True Tide, 4:55 Speaker 2: know, all the GLP-1s and things like that. So we had 4:58 Speaker 2: a great conversation and a lot of the things that we've kind of talked about at that time are kind of to a degree come to fruition 5:06 Speaker 2: now. 5:07 Speaker 2: Not to say go us, we just, you know, kind of have some of the foresight into that stuff, but I do, I want to kind of, you know me well, man, I want to cut to the jugular 5:17 Speaker 2: and, you know, talk about the big fat elephant sitting in the room that everybody probably wants to hear, which is, 5:25 Speaker 2: what the hell happened to peptide science? 5:28 Speaker 4: Yeah, that's a great question. And that just all went down this past weekend, right, where when you went to their website, you would see that it said, hey, we're shutting down shop. Thank you so much for all the years. 5:39 Speaker 4: So allegedly, and I was next to a 5:43 Speaker 4: couple of really great attorneys that are in the know as this was happening 5:47 Speaker 4: in real time. And allegedly, what had happened with them was it had nothing to do with with research peptides at all. It actually had nothing to do with peptides whatsoever. 5:57 Speaker 4: It was allegedly, again, their credit card processing that they were doing offshore. 6:01 Speaker 4: And it seems that there was something going on where things weren't being reported the way that it should have been, so on and so forth. And again, the best way I can say is, allegedly, 6:11 Speaker 4: this is what's what's been going down with them. 6:13 Speaker 2: So allegedly, so you don't feel in any way that it had anything to do with the FDA or any type of regulations or anything like that? It was just strictly a credit card processing. You're absolutely correct, man. 6:26 Speaker 3: Correct. So let's 6:27 Speaker 3: stick on credit card processing for a 2nd. Sure. 6:31 Speaker 3: Tell 6:32 Speaker 3: everybody, so, 6:34 Speaker 3: everybody, just so you know, like you go to these different peptide websites and not all of them accept credit cards. The reason is- Well, still. 6:43 Speaker 3: These peptides are handled kind of like cannabis, 6:46 Speaker 3: right? The 6:47 Speaker 3: banks think that customers are super high risk, right? They think that the customers buying peptides are super shady for some reason, doesn't make any sense, but it's a good way for banks to the banks know that there's a lot of money being spent and they can make a lot of money and so they're just gonna do their best to tax it. So essentially like you're a company and you wanna have a credit card processor, 7:09 Speaker 3: you're paying 10% 7:10 Speaker 3: of 7:11 Speaker 3: every dime that you make and they, the bank takes it goodbye, gone. You're taking another, they're taking another 10% 7:18 Speaker 3: and paying that back to you 6 months later, 7:22 Speaker 3: assuming you don't have any charge backs, right? So every dime that 7:26 Speaker 3: a company makes, they take 20% of it right then and there. And 7:30 Speaker 3: that is if you can be 7:33 Speaker 3: even approved, right? And then you get a processor and it usually stemmed, it usually is there for maybe a couple months max, 7:41 Speaker 3: and then it gets shut down. The bank goes, oh, you're you're you're 7:46 Speaker 3: charging too much money or you're accepting just too much money, right, because you're a business and you wanna accept money. Right? I think that's thought that was the point. But, 7:55 Speaker 3: nope, you're taking too much money, so we're gonna shut you down and all the money that we have in reserve and all the money that we may still have that we didn't give you frozen 6 gonna freeze that. We're freeze it and not give it to you. Yeah. So you'll see a lot of these 8:06 Speaker 2: product companies 8:08 Speaker 3: accepting Zelle, Venmo, 8:10 Speaker 3: catch up, Bitcoin, 8:12 Speaker 3: and I guess to the viewers like that's not shady. 8:16 Speaker 3: Realize, I think, you know, a lot of people would say, Hey, if I'm not paying with a credit card, there's something must be wrong. Right? Well, yes, it was wrong, but it's the bank's fault. 8:24 Speaker 3: It's not like this. The company is the online company is shady. That's just standard. This is just how those are what people do gotta do to try to make a living, 8:33 Speaker 3: and to get around. 8:35 Speaker 3: Yeah. It's not even, I mean, it's less about the fees, which are crazy. 8:39 Speaker 3: I mean, not to mention, so 20% gone, then pay another 45% 8:43 Speaker 3: in taxes. There's very little leftover for a company to 8:46 Speaker 3: make. But 8:48 Speaker 3: it's more about like, God, the consistency, 8:51 Speaker 3: right? And I always have a new process or blah, blah, blah, getting shut down, frozen. Sucks. So a lot of companies will just resort to Venmo, 8:58 Speaker 3: Zelle Cash App, and that is what it is. 9:01 Speaker 3: And crypto. Yeah. FYI and crypto, and I guess direct 9:06 Speaker 2: like a bank account to transfer, right? Enter an account routing number automatically, and then it can get, you know, people have heard that like, or the ACM clad 9:15 Speaker 3: that, it's basically an ACH transfer. All those things are just normal standard practice and don't be alarmed. 9:21 Speaker 3: I mean, always be a good consumer and watch yourself, but 9:25 Speaker 3: that's about standard for peptides. 9:27 Speaker 2: Well said. So just FYI to people. I think most people at this point, because, you know, as we all know, sitting here, I mean, peptides have just blown the hell up. I 9:36 Speaker 2: think most people at this point, you know, if we talked a year ago, that would definitely be a different conversation, 9:41 Speaker 2: but I think most people are getting it, you know, they're, they're most people are getting that's kind of how it works. 9:47 Speaker 2: Let me ask you this. What do you think, do you think that's going to stay the same? Do you think it's ever going to get better? Probably not because of the gray area that, 9:56 Speaker 2: those companies swim in. 9:59 Speaker 4: You know, as long as the gray area stays gray, that's pretty much where we're gonna stay when it comes to the banking. 10:05 Speaker 4: And that's why going back to last end of last year, the last time that we all met, we were speaking about the changes that were happening with with peptides getting approved, 10:15 Speaker 4: and now we're starting to see that happening. Right? And we knew that all the rage, and it still is quite frankly with Retatrutide, with the GLP-1s. With Retatrutide 10:23 Speaker 4: Right. And Eli Lilly, all these companies, big pharma coming in and really creating the monopoly on retrutide, 10:29 Speaker 4: getting that getting that to go through FDA approval. We really thought that we would see that get FDA approval 10:35 Speaker 4: earlier this year, and it seems like it's still ongoing. But what we have seen now is, as we mentioned in our last podcast together, about 25 to 40 peptides were gonna start to move out of where they're at in the gray area from the do not compound list. And now Yep. We're seeing about 14 to 19 move into category 1, which means 10:54 Speaker 4: that they're gonna come back into the compounding pharmacies of 5 0 threes where a doctor can write a prescription for those and get that sent out to a patient. So 11:03 Speaker 4: that's where I see things are gonna continue to move forward in that regard. And the reason why I say that is because as they get more regulations 11:12 Speaker 4: to move the peptides into the category ones, 11:15 Speaker 4: that's where they can control it more and they can have the doctor prescription and guess what else comes with that? Credit card processing. 11:22 Speaker 2: So that's where they're gonna be able to charge and do those things. Somebody listened to the, to the, to the podcast that, that, you know, is kind of new to peptides and just new to this world. 11:33 Speaker 2: If you can kind of dissect that a little bit, what does that mean to the consumer? Like, what does that mean towards, 11:40 Speaker 2: people that 11:43 Speaker 2: it just, you know, trying to buy peptides and people that have been going through like a research 11:48 Speaker 2: peptide company compared to like, 11:50 Speaker 2: you know, if doctors can actually 11:53 Speaker 2: prescribe those, what's that gonna do to the market? Great questions. 11:58 Speaker 4: Little bit, and I know that your viewers, if they've seen this a little watched us a few times, I won't be too much of a broken record, but just a little bit about my past. 12:06 Speaker 4: I was the patient care director for some of the largest online clinics telehealth in the country. Right? So what I would see back in, let's say, 2022 12:15 Speaker 4: before the do not compound list actually happened for things like Tesamorelin, 12:20 Speaker 4: BPC, 12:21 Speaker 4: all of these great peptides that we all know and love. I'll 12:25 Speaker 4: give you an example. 12:26 Speaker 4: And it's again, not all telehealth is gonna be doing this, but back then, what what happened was is that 4 months of Tesamorelin 12:33 Speaker 4: was right around $4,000 12:35 Speaker 4: supply. Right? And I remember the number vividly. It was $39.74, 12:39 Speaker 4: $3,974 12:41 Speaker 4: for a 4 month protocol of Tesamorelin. Now 12:44 Speaker 4: when you go into a research use website, you're gonna see that same vial of Tesamorelin, for example. Let's, you know, I'll just use round numbers. I'm just making it up. Let's just say it's a $100. Right? Just a $100. Okay. So 4 months of Tesamorelin from that kind of a site is gonna be dramatically, 13:03 Speaker 4: infinitely less than paying 4,000 So 13:05 Speaker 4: that's gonna be the major difference that that folks will see. The beauty is is that us living in America, we have the freedom of choice. Right? So but the there's there's a Latin saying called caveat emptor, which means buyer beware. Right? That's in everything that that we have here in The United States. So that means that you need to be educated as a consumer to understand where you're getting your peptides from, how you're getting them, where they're sourced from, and is it a trusted source? 13:30 Speaker 4: And then move forward in that regard. But, yeah, that's that's a great question, JD. So when it goes into the 5 0 3, the compounding pharmacies, and then it's gonna go through a doctor's prescription, you might see a little bit of a price change. Yeah. Mhmm. I'm thinking, like, you know, you gave us the round number, and it's about right. So I'd say for about 3 months to Tesamorelin on a typical research site, you're probably paying about $600. 13:51 Speaker 2: Right? Maybe 2 bottles a month We'll get you about 2 bottles less a month. So yes, 600 is a awful lot less than 4,000. Little bit. Little bit. More 14:03 Speaker 2: hands got to get into the pot through that route. Right? Let me ask you a question, man. Mean, if the government touches anything, does it get cheaper? 14:11 Speaker 2: No. I'm 14:12 Speaker 2: 48 years old. I haven't seen it yet, but it might be coming. So Pogue, off the top of your head, tell us, 14:18 Speaker 3: if you know, what are those 14 to 19 peptides? 14:21 Speaker 4: Do your best at that that giving us a list of which ones You know what, I actually wrote the entire list out the other day and if you put a gun to my head, 14:28 Speaker 4: only 1 that I'll remember right now is BPC. BPC. Alright. But it's 14:33 Speaker 2: most of the big popular ones. Yes, is. Sure. Yeah. Okay. 14:39 Speaker 2: Figured. Yes. Good. So what's that going to do? Because I 14:43 Speaker 2: mean, 14:43 Speaker 2: has their favorites and I think, you know, the gateway drug, so to speak, for a lack of a better way to say it, is either BPC 14:50 Speaker 2: TB-five hundred or 14:53 Speaker 2: any 1 of the GLP-1s. 14:54 Speaker 2: You know, a lot of people start there for rightfully so. You know, they, they try those, they work really well. And then they try multiple peptides is what, you know, what we see often. 15:06 Speaker 2: But people are going to want to know obviously about the GLP-1s, 15:10 Speaker 2: obviously specifically Retatrutide. 15:12 Speaker 2: What is this going to be? What is this going to mean for that? Like, what does this, this whole, what does all this do 15:20 Speaker 2: for Retatrutide? 15:21 Speaker 2: It's been supposed to be FDA approved, 15:25 Speaker 2: it's been pushed out, but as we move forward in 2026, 15:29 Speaker 4: what's your foresight? What you think's happening? What's that going to do to Retrutide? Well, we know what's gonna happen is is once the final approval comes down through the FDA because of all the clinical testing and trials that they've run, 15:42 Speaker 4: from big pharma on Retrutide, 15:44 Speaker 4: that is their that is gonna be their drug. They own it. They've taken it through all the trials and testing. They own it. And that means what does that actually mean when I say that that's their drug? It means that they're gonna be the only ones that are going to be able to compound and supply it. So if you want Retrutide, 15:59 Speaker 4: you're gonna be going through Eli Lilly. Right? And they're gonna be the ones that are gonna send it down to the compounding pharmacy, from their compounding pharmacy, from the doctor's prescription to go out to the patient. 16:08 Speaker 4: So does that mean that there's going to be other variations of a triple agonist 16:14 Speaker 4: glucagon like peptide 1 compound out there that could potentially be mixed with something else? 16:21 Speaker 4: Of course, there will be. Right? Right. And then how long does that last? We don't know. That's why it's kind of this this guessing game, if you will, where we're trying to see how long you're gonna have access to it. But at the end of the day, will access always be there for Retrutide? Yes. But it will be through the big pharma and a doctor's prescription. Will there be other avenues? 16:41 Speaker 4: Yes, but you don't know how long that'll last because if there's 1 thing we know about big pharma is that they don't play around when it comes to their drugs that they paid for. 16:48 Speaker 2: Yeah, they're pretty big. Price will skyrocket. 16:52 Speaker 2: They wanna run this prescription only. They wanna run the price. I mean, it's supply and demand. Right? If they have all the supply, they can demand whatever price they want and people will buy it. That's typically how monopoly works, man. Yep. 17:05 Speaker 3: And I will play devil's advocate real quick. Like, 17:08 Speaker 3: I know people like, oh, bad, big pharma. Well, I will say that, they did spend a lot of money and develop this drug themselves, and so they do kind of have the right for to do the drug. So Yeah. And you can understand they there's a lot of bloods blood, sweat, and tears that they put into into that. You're 100% right, Will. And 1 thing I wanna mention to you guys, just just to point this out to the audience, 17:30 Speaker 4: is that, 17:32 Speaker 4: look, when it comes to peptides, right, and people go, oh, it's not FDA approved, this, that. Okay. So let's break that down. 17:40 Speaker 4: Aren't vitamin c, b 12, creatine, 17:43 Speaker 4: protein. None of these are FDA approved either. Right? But we all use them on a daily basis. The other part of this is 17:48 Speaker 4: that when it comes to FDA approval in peptides, 17:53 Speaker 4: does that mean that a peptide is not gonna be efficacious 17:57 Speaker 4: or safe, or does it mean that it's not gonna be something that's gonna be life changing just because it's FDA approved? Absolutely not. We all know that. Right? 18:04 Speaker 4: But what you have to think about is why is it not FDA approved? Let's talk about that just for a moment. Why is it not FDA approved? Well, some of these peptides aren't gonna be FDA approved, not because they don't work fantastically well. It's because there's no money in it for big pharma to do something about it. But why is Retatrutide 18:21 Speaker 4: and these GLP-1s 18:23 Speaker 4: looked at so profitable? 18:25 Speaker 4: Right? And and for them to want to FDA approve it is because it's actually projected that Retatrutide 18:30 Speaker 4: alone in the next 10 years is gonna be 1000000000000 dollar compound. 18:34 Speaker 4: So that's the big difference that I just want the audience to really think about and know. It's not that they don't work. It's not that they're not safe. It's not that they don't make sense. It's just that there's no money in it for them to want to take it through the clinical trials 18:46 Speaker 4: for the FDA approval. So that's a big difference, guys. That's good. That's thank you for that clarification. 18:52 Speaker 2: Yeah. And that, so that happens. So, so they, it gets FDA approved. Yeah. Lilly is the king of the castle, so to speak. What's that do to the other peptides? 19:02 Speaker 4: What's that do to the rest? What's that do to the other peptides? Meaning 19:05 Speaker 2: like, are 19:07 Speaker 2: like research companies 19:10 Speaker 2: going to be still in existence? Do you think those will fall at the wayside? 19:14 Speaker 2: What do you think those will do for, smaller companies? No, great question. So when, once that approval happens, 19:22 Speaker 4: I'll say this, 19:23 Speaker 4: will the research companies still be in existence? Yes. But they're gonna be playing that fine line when it comes to to things like GLP ones and and whatnot because Yeah. If they start to go down the route of 19:35 Speaker 4: making too much noise or marketing in the wrong way when it comes to GLP ones, they're gonna get that cease and desist really quick from big pharma. 19:44 Speaker 2: Okay. But, 19:46 Speaker 2: you know, peptides have grown so fast and so much. 19:49 Speaker 2: The obvious reason is because they work. They are freaking amazing. 19:54 Speaker 2: They are healing people 19:57 Speaker 2: with so many companies and just like any company, I mean, like 20:02 Speaker 2: sports companies, you know, where they sell footballs, whatever, some are good, some are bad, right? 20:06 Speaker 2: But 20:07 Speaker 2: with that many companies able to get access and whatnot, I mean, can they even, I mean, can they dent that many companies? I mean, 20:16 Speaker 2: you know what I mean? They don't have they don't have that much manpower 20:19 Speaker 2: to be able to stop the sale of that product. 20:22 Speaker 4: No. And you'll be surprised, right? Because the things that they're looking at is who's the biggest players in the industry. Right? So I'll give you guys an example. I have some insider information that I know, and now that Peptide Sciences is defunct, I'll I'll talk about this. But we know that back when we met last time in December, 20:39 Speaker 4: a couple months before that was was a a big we'll just say a big summit. I'll I'll let everybody use their their spidey skills on on thinking about what it is that I'm talking about that went down in DC back in, like, September, October time frame. And 20:55 Speaker 4: Big Pharma literally told Peptide Sciences, hey, guys. We we've got a cease and desist ready for you guys come January. 21:01 Speaker 4: Because once January happens, we're not gonna allow you guys to make the triple agonist or GLP r, GLP 3, whatever you guys wanna call it because we know what you guys are doing, and that is now gonna be our drug. Right? So that's who they're looking at more than anyone. And as long as Chronic migraine, 15 or more headache days a month, each lasting 4 hours or more, can make me feel like a spectator in my own life. Botox, onabotulinum 21:23 Speaker 1: toxin A, prevents headaches in adults with chronic migraine. It's not for those with 14 or fewer headache days a month. It's the number 1 prescribed branded chronic migraine preventive treatment. 21:33 Speaker 2: Prescription Botox is injected by your effects of Botox may spread hours to weeks after injection, causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems, or muscle weakness can be signs of a life threatening condition. Patients with these conditions before injection are at highest risk. Side effects may include allergic reactions, neck and injection site pain, fatigue, and headache. Allergic reactions can include rash, welts, asthma symptoms, and dizziness. Don't receive Botox if there's a skin infection. Tell your doctor your medical history, muscle or nerve conditions, including ALS Lou Gehrig's disease, myasthenia gravis or Lambert Eaton syndrome, and medications, including botulinum toxins, as these may increase the risk of serious side effects. Why wait? Ask your doctor, visit Botox Chronic Migraine dot com, or call 22:14 Speaker 4: 40 to learn more. These other research companies are doing the doing the right thing and marketing the right way and playing by the rules, they'll be fine. But the 2nd they go into 22:25 Speaker 4: hitting the pockets of big pharma, that's when they're gonna get in trouble. Peptide Sciences sales were probably responsible for well, let's just say, you know, 22:34 Speaker 3: maybe this is kind of even more of an 22:37 Speaker 4: in proportional eightytwenty rule, but like Peptide Sciences and a few others were probably responsible for 98% of the total sales. Probably a safe bet. You know, it was Of that company. Of that company. It was rumored or or, you know, again, I love the word allegedly right now as my attorneys tell me to say all the time. But it was it was allegedly 22:54 Speaker 4: they were, they were doing about, you know, dollars $210,000,000 22:57 Speaker 4: in revenues a year. 23:01 Speaker 2: Not, not to cut that short, but I heard more about that's a man. You're doing all right. Yes. Yeah. 23:07 Speaker 3: And I've had yes. Anyway. And they were taken down by our credit card partners. Yeah. Credit card I guess I want to touch before we forget, I guess I want could you please clarify the difference between these 14 to 19 peptides that we're saying that you're saying are, you know, being pushed through and 23:23 Speaker 3: Retatrutide's 23:25 Speaker 3: approval. Right? There's a huge difference on the approvals. We're not talking about the same approval. 23:29 Speaker 4: Back in 2022, 23:32 Speaker 4: 2023, 23:33 Speaker 4: when big pharma was essentially pulling on the strings of their lobbyists down at the FDA to to tell the FDA, hey, guys. Put all of these peptides on the do not compound list because essentially what they were doing was they were looking into these peptides. 23:46 Speaker 4: They said for safety, for efficacy, for efficiency. 23:49 Speaker 4: Some may argue that it was so that they could figure out how to patent some of these or take them through the, the approval process so that they could control it like what we're seeing with with Retatrutide. Right? Some may say that. 24:00 Speaker 4: The thing is is that when it comes down to the difference between what what they're doing with retrutide and getting its FDA approval, 24:07 Speaker 4: that means that it's gonna be with a prescription through a doctor, FDA approved, they own that drug. 24:13 Speaker 4: The 14 to 19 that are now being stated that they're going to put into category 1. So what does that mean? It means that they're taking them off of the do not compound list, 24:24 Speaker 4: and then they're going to allow the compounding pharmacies, the 5 0 threes that we that we keep mentioning, 24:29 Speaker 4: allowing the 5 0 3 pharmacies to compound them again the way that they were doing back in 2022. 24:35 Speaker 4: And I wanna say it was and it stopped back in '23 or maybe it was '22, 24:40 Speaker 4: because I remember when it was when it happened 24:43 Speaker 4: because I was still, you know, neck deep in in telehealth at that time. 24:47 Speaker 4: And when they did that and they put them on the do not compound list, that meant that no doctor, no compounding pharmacy could make them anymore. And that's when they went into really heavily into the research space. 24:59 Speaker 2: Right. So 25:01 Speaker 2: again, what's that going to be due to the price? Up. 25:04 Speaker 2: You know, there I'll give you I guys know that's rhetorical 25:07 Speaker 2: to me, but I know there's people asking that don't know. They're always gonna 25:11 Speaker 4: the scariest thing in the world to me besides besides, you know, war and everything like that, but 1 of the scariest things in the world to me is when the government knocks on your door and says, hi, we're from the government. We're here to help. 25:25 Speaker 2: A Reagan 25:26 Speaker 4: quote, baby. Yeah, man. 25:28 Speaker 2: Telling it. That's great. With, 25:32 Speaker 2: with, 25:34 Speaker 2: peptides just being as amazing as they are, 25:38 Speaker 2: This is obviously just a personal question. Do you 25:41 Speaker 2: think they're going to start pushing pharmaceutical 25:44 Speaker 2: out? 25:46 Speaker 2: You know, I mean, pharmaceuticals are gonna be always be there, but like they work so well and they're so healthy. 25:52 Speaker 2: And, 25:53 Speaker 2: you know, with some of the pharmaceuticals 25:56 Speaker 2: that people take, they're destroying our guts. There's such a movement for people to get healthy. 26:02 Speaker 2: People feel like shit, you know, and like they start taking peptides, they start like, Oh man, I forgot what it feels like to feel good again. 26:10 Speaker 2: So with the power 26:12 Speaker 2: of 26:13 Speaker 2: how amazing those are, what's your take on, do you think they're going to push 26:20 Speaker 4: Western medicine to a degree to the side? I mean, if you break your arm right, you need a doctor, but like, you know what I mean? Does that what do you think about that? Brother, I'll say this. We can only hope that it does. Right? We can only hope that it does. And just this last week, a study came out. Right? This is public information, so everybody can just look this up. There was a document that came out from the CIA 26:42 Speaker 4: that they had found a cure for for cancer. 26:46 Speaker 4: Now it's not that they found a cure for cancer that was a big issue. The issue about that document was that it was 60 years old. 26:54 Speaker 4: Yeah. Yeah. Yeah. You know? So we can only hope that that's what's gonna happen. No. No way. Shocker. 27:00 Speaker 4: Right? No way. You blew my mind. The thing is, man, is that when it comes to peptides and the reason why they're so popular and the the reason why we can only hope 27:10 Speaker 4: that they will really push Western medicine towards this this route as opposed to, you know, just putting a Band Aid on things with pharmaceuticals. 27:18 Speaker 4: And the reason why it's happening, is because of guys like you 27:22 Speaker 4: and the people that are listening to this podcast 27:24 Speaker 4: and the people that are actually talking to their doctors and bringing it up. Right? Because I can't tell you how many 27:30 Speaker 4: professional 27:31 Speaker 4: medical doctors and surgeons that I speak to that don't know about peptides that are now hearing it from who? Their patients, 27:38 Speaker 4: their clients. Right? And that's what's really pushing this forward. So we just gotta keep up the good work that everybody's doing here with working from their heart and going, hey. Peptides are great. They're signaling molecules that are actually working and healing people. Let's talk about it. And that's what's making the feds and everybody look at it as well. But yeah, we can only hope that it's going to push that Western medicine in that way. 27:58 Speaker 2: Yeah, Duche. I, it is, it's funny you say that because, know, it's not only that, it's 28:05 Speaker 2: baffling that 28:07 Speaker 2: the amount of medical doctors that people go to see, and we trust them, you know, we have trusted them now. I think that trust in the last 6 years or so has been shaken obviously from most people. 28:20 Speaker 2: But it's amazing the amount of trust that we gave doctors 28:24 Speaker 2: to just take these pills and, you know, just have destroyed our guts and our gut biomes and whatnot. And it's amazing to me and Will and I talk about this all the time to the point of nausea, but we love it. But even 28:37 Speaker 2: the fact of the doctors that don't have a clue about any type of hormone levels or like what's a healthy level or 28:45 Speaker 2: a man that's at 2 50. They won't prescribe testosterone 28:50 Speaker 2: replacement. 28:51 Speaker 2: I mean, now there's a movement and it's just like peptides. 28:55 Speaker 2: Some of the doctors that are using the brain are seeing the train coming and they're starting to get it. 29:03 Speaker 2: And I mean, shoot, we have doctors that listen to this podcast that, you know, like we're not doctors, we're just 2 dudes. We've just, for 29:12 Speaker 2: lack of better word, studied it for years because we were so intrigued by it, you know, and it's still studying it that, you know, but we still like, we do know more about than doctors because they don't open their minds to it. They don't, lot of doctors don't even know about nutrition because they've never studied it. 29:28 Speaker 2: You know, that's, it's just kind of amazing that we've given them so much trust. But like I said, I mean, I think there's such a movement within 29:37 Speaker 2: the world, at least The United States, but I think the world to get healthy again, truly healthy. I think people are sick of feeling like shit for lack of a better way to say it. And they are seeking different things. That's why this podcast has grown quickly. There's nothing special about these 2 dudes sitting here. 29:55 Speaker 2: We just have shined a light on some things that people didn't know, and now they are starting to seek deeper. 30:02 Speaker 2: And it's like that, 30:04 Speaker 2: that rabbit hole, so to speak, that everybody has to go through. And then that cognizant breakthrough that we all finally get through and it's like, the world's so different than I thought. You know what I mean? No, man. And you know what, JD, to your point, I want to I want to tell you guys this because, look, 30:19 Speaker 4: not only do I love working with you guys, but obviously I'm a fan. I watch what you guys do. And the change that's happening right now is when when patients, when people are actually speaking to their doctors and they're bringing up peptides to them. Yep. You need to watch the way that doctor reacts. If they just brush it off, they don't wanna talk about it. Right? That's not a great sign. But if they start to open their mind, they go, oh, well, tell me more about that. Let me do some research and get back to you. That's huge. And my hat is off you guys because I watch your podcast, obviously. I'm a fan 1st and foremost. You guys have had the right kind of doctors, the right kind of medical professionals on your podcast that are talking about this stuff, and they go, oh, yeah, man. I get it. I understand. I see what's going on. I hear you guys. I know what you guys are up to. So that's what really matters, and that's what's pushing this conversation forward for us to, you know, no pun intended, for us to literally make America healthy again. 31:06 Speaker 4: And it's and it's working, Yeah. 31:09 Speaker 3: That's true, man. So in my, in my free time, I like to do things things that maybe people would say I'm a nerd, but I was like having, I was writing like a mission statement for this 31:18 Speaker 3: podcast, right? And 31:20 Speaker 3: as I thought about it and wrote it more, like literally the mission 31:24 Speaker 3: for me is to basically like further, is to further R and D of peptides. Like that 31:30 Speaker 3: is the bishop, right? These aren't controlled tests, but really to just get out more research and development. Right? 31:36 Speaker 2: Well, research, 31:38 Speaker 3: with the masses, because that's the only way that we're really gonna people are gonna find out about peptides and how really they work and etcetera, etcetera. 31:47 Speaker 3: Not to make money like we sure as hell didn't start this podcast 31:51 Speaker 3: thinking about making money. 31:53 Speaker 3: But really, yeah, kind of the impetus there is to kind of just further the research and development of peptides in general 32:00 Speaker 3: and see where that takes us. 32:02 Speaker 3: Because there's a whole bunch of good stuff that these things do. Speaking of, did you see did you see the podcast that we did with, with Lee, 32:10 Speaker 3: who is the owner of the, 32:13 Speaker 4: what's name? Yeah. Wellness Center. Service. Yes. That's actually what I was referring to, man. We wanna I agree because I do that, and I go, well, you guys are getting the right people on there. Their their light bulbs are going off and they get it. Right? Yeah. And to your point, Will, the other thing I wanna I wanna give you some some flowers for is the kids are saying these days. Right? 32:31 Speaker 4: I saw 1 of the posts that you made. I don't know if it was a post or a podcast, 32:35 Speaker 4: but you were talking about Dihexa, and I couldn't be any more proud of what was going on. So full disclosure to the audience, JD and Will, they they suffered. You know, I was gonna say they suffered through my training of of of all the peptides and stuff, so God bless you guys. But what you're doing with it now, where you've taken it, I go, dude, look at these graphics. Look at what they're talking about. He's talking about the dendrites and synapses. I loved it, bro. I was I couldn't move out. Wait. Yeah. We got more I got more coming. I was just working on my tuning in. Comparing 33:03 Speaker 3: I I thought, frankly, that we were gonna do this and do, like, a compare contrast of the GLPs. And so dude, I got some cool, I had some really cool graphics. I did see that with Lee. I did see that. Yeah. Okay, cool. Yeah. It's so funny, Paul, because you've known us, you know, from the conception of this company and 33:23 Speaker 2: the genesis of this is, us being in Vegas and I'm like, well, we need to sit down and we need to talk about a peptide for like 10 minutes, dude. And then I think it was going be for my YouTube. And then we did a couple, like we tried doing it on the beach. We were going to do it on a different beach in Orange County. Like, you know, that's how everything starts. You just start tying things and the people are like, I can't hear it, you know? And then like, 33:43 Speaker 2: just started doing it and then like over, I'd be at my office at home. He'd be out the office, you know, our old office. That 33:49 Speaker 2: was just the Genesis of it, And it's funny because he will, will is just, you know, he was a little bit kicking and streaming doing it because he didn't know this neither of us had a clue this would turn into even something. Were at a studio now because it's done so well, but 34:05 Speaker 2: it's because 34:07 Speaker 2: I believe that when you try to do good, regardless, God puts his hand on it, you know? Absolutely. So it's been a blessing, 34:14 Speaker 2: you know, and then we get to touch the people that listen 34:18 Speaker 2: on the Q and A's because they write in and do there's people in Scotland, there's people in like Australia and it's like, it's rad, man. People are seeking health 34:28 Speaker 2: all over the world. 34:30 Speaker 2: To be a little piece of some of that as a blessing, man, all 3 of us dude, like sometimes, 34:35 Speaker 2: man, I wake up, prayed, I'm meditating stuff. And I'm like, I just look up. Thanks, man. 34:40 Speaker 2: Appreciate you. God's hands are all over it, bro. Any new, any new, I know we asked this last 34:47 Speaker 2: peptides coming down the pike? Anything new? Because you always have your, 34:51 Speaker 2: you know, nose to the grindstone a little bit, you know, and and know what's coming down. Anything new coming? I'll give you guys 1 that I actually just started 34:59 Speaker 4: 2 days ago. 35:01 Speaker 4: It's it's actually a a 35:03 Speaker 4: different variation of Follistatin, 35:05 Speaker 4: FLGR 35:06 Speaker 4: 2 2 4, and I'm maybe butchering that a little bit. Campbell talking about this all the time? Jay Campbell? 35:11 Speaker 4: That 1 you know who, Brian Moscow is? Good friend of mine. He's a biochemist out from UC Berkeley. Super brilliant guy. 35:18 Speaker 4: And he's the 1 that actually 35:20 Speaker 4: brought that to my attention, and I've seen some pretty amazing stuff with that, man. Amazing stuff. Guys putting on 20 pounds and I go, know what? I'm gonna try that out myself. So I'm, that's why I hit you guys up earlier today and I go, hey, man. I I need to pick up some other stuff so that I can I can get this this spring summer body going? You know? We're never too back from the Arnold Classic, Doug. Yeah. Exactly. Exact. After being at the Arnold Classic, I go, I gotta get my stuff together, man. Yeah. That's right. 35:47 Speaker 3: No doubt. 35:48 Speaker 3: Well, that's cool, man. I'm gonna look into that. What's name of that 35:52 Speaker 4: again? FLGR-two 35:54 Speaker 4: 24. 35:55 Speaker 3: So, 35:56 Speaker 3: speaking of kind of follistatin ish, so we have a good friend, 36:00 Speaker 3: who's actually been on this podcast before, 36:03 Speaker 3: but so you know those Belgian blue bowls? Yes. So you've seen pictures of these bowls that look like somebody's been just injecting them with nothing but steroids forever, 36:12 Speaker 3: just rippled out with muscles. Well, that is like a natural condition for those bulls. Yep. They, 36:17 Speaker 3: in their genes, they just have something that does not shut off, doesn't tell them to stop growing muscle, and doesn't tell their body to stop burning fat or at 36:27 Speaker 3: least their body can't meet, isn't told to 36:30 Speaker 3: build fat. Right? So doctors have, 36:34 Speaker 3: in different countries, 36:36 Speaker 3: have bottled that 36:38 Speaker 3: and now offer it as an injection to people. So we had a friend who went down to Mexico 36:43 Speaker 3: and got the injection of it. And it's supposed to be like that 1 injection, but last year 4 years and changes kind of your, how your genes 36:51 Speaker 3: work. 36:52 Speaker 3: That's exciting. You just, that's exciting right there. I don't think he said he felt anything though. He didn't. I think he did. You know, he here's his plan. He's like, yo, yeah, bro. Like, I remember him trying to justify the money portion of it and be like, look, yeah, I know it's 5. It's like $15. Right? But 37:07 Speaker 3: the all the money I spend on supplements, right, on all of my, like, tests and peptides, etcetera, 37:14 Speaker 3: I don't have to do any of that stuff. I just got this. Right? And I just don't think that he really got a good result because of course he didn't stop all the other shows. Right? We 37:22 Speaker 2: love you, buddy, if you're listening. I'm 37:25 Speaker 3: always supposed to say that, but they don't, at the end of the day Yeah. Don't stop at all. Yeah. And I think at the beginning, I haven't talked to him recently, but he did say he noticed it. Now he sure didn't look. I mean, he didn't put on 60 pounds of just pure muscle, and he was already in good shape. He was all he's always been in really good shape. So I don't know. I don't know if 37:44 Speaker 3: I don't know how well he really said it worked, but I think he did say it worked a little bit. Know. 37:49 Speaker 2: Good. 37:50 Speaker 4: 1 thing I just was gonna tell you guys that I that I've said for years in all in all the years that I've been in in telehealth and even now when I'm when I'm talking to folks 1 on 1 that asked me about peptides or they might go, hey, man, this kind of didn't work or I don't know if this was working. And I I will point blank look at everyone in the eye and I just go, listen, 38:08 Speaker 4: all these compounds, these medications, you know, if you're on hormones, peptides, whatever you're on, they're wonderful. They will work. But let me say something, They will only work as hard as you do. 38:19 Speaker 4: That's it. 38:20 Speaker 2: My drop dude. Like, dude, like you can't sit on the count and chat to not change your life, dude. I mean, we talk about it so much, Paul, like 1st and foremost, if your hormones aren't optimized, 38:32 Speaker 2: dude, and you're over 40, you're doing it wrong. Like you are swimming up a hill or you're just walking up a hill or swimming and it's a stream, like get your hormones in line and for the love of God, the obvious is workout and eat right. Like change your darn lifestyle. 38:47 Speaker 2: And then the peptides will fly. 38:50 Speaker 2: They will be amazing. Amplify. 38:53 Speaker 4: Might work a little bit. Why would you want it to work a little bit? They're not cheap. Like, if you're gonna do it, do it well. 100%. And you're the shining example of that, JD. You actually live and walk it and talk it and do you practice what you preach, basically, is what I'm saying. And the thing is is I go I go when people tell me, oh, I just lost, like, 8 pounds, and I go, you lost 8 pounds and did nothing? I go, 1st of all, that's amazing. 39:14 Speaker 3: 2nd of all, imagine if you actually did something, like, how much more you would lost and how much better you would have felt. So yeah, man. Or we hear this a lot. Like, it's just it didn't do anything for me. You know, I've only lost 20 pounds in 2 months. So it doesn't work. 39:28 Speaker 3: Seriously. Like, it's only 20 pounds. Are you listening to yourself? Right? Yeah. How long did it take you to gain that weight? Anyway, 39:35 Speaker 3: yeah. 39:36 Speaker 2: Agree. It's like funny because, you know, any GOP-1will 39:40 Speaker 2: give instant gratification, 39:42 Speaker 2: but it's like, I want more. 39:44 Speaker 2: Sit on the couch and I'll do shit, eat some Twinkies and lose 50 pounds in a week. 39:48 Speaker 4: If only. 39:50 Speaker 3: Yeah. So, hey, Paul, what are your personal 39:53 Speaker 4: top 5 peptides? Just how about in life, what do you actually take? What are your top 5 peptides that you mostly take? Let me take a jab at this. Right now what I'm doing- See you again. Great. I love this question because you guys already know. Was we were talking before we started the podcast. I was like, hey, guys. I gotta get my stuff together. You know? And and thanks for pointing that out that that it was Arnold Classic that did it to me. That was a good motivator right there. But Yeah. The I'll tell you. For me right now, 40:18 Speaker 4: what I'm taking is I'm taking SLU-3P, 40:21 Speaker 4: right, the exercise mimetic. 40:23 Speaker 4: Really like that 1. I take a milligram of that in the morning fasted. 40:26 Speaker 4: And then I take that with 150 mg of 5 amino 1 m q oral, both of those. 40:31 Speaker 4: That's gonna go after the white adipose tissue, that that stubborn body fat. Right? Because, 40:36 Speaker 4: you know, hey, man, I'm I'm Persian. I'm 44. I keep the love handles no matter what I do. So I that that those 2 right there helped me out tremendously. 40:43 Speaker 4: While I'm doing that, of course, I'm like everyone else where I'm trying to lose body fat and gain muscle. So what did I add into that? What you to add? Was the FLGR that we were just talking about. Okay. Got that going and a little bit of Tesamorelin in addition to my 200 mg a week of test Cypionate bio identical from my TRT. So that's what I'm doing right now. 41:05 Speaker 4: Hell yeah. Thank you. Nice no Retatr for you. Good. Okay. 41:08 Speaker 4: Right now I go, you know what, let me get this going and then I'll start to microdose Retatr about a milligram, maybe a week every other week because I'm such a small guy. I'm only like five'nine, 180 pounds. I'll wither away, you know? 41:20 Speaker 3: Yeah, for sure. Hey, now speaking of Dihexa, so in 41:24 Speaker 3: the presentation and podcast we did, Like Dihexa is not 41:28 Speaker 3: kind of 1 of the main points there was like, this isn't something you don't take this for like, I'm take it right now and my brain is going to be bang firing, right? Like Modafinil. 41:37 Speaker 3: Okay. It's a But that being said, 41:41 Speaker 3: you, I know that you have taken it like before a presentation to make it to for instant results. I also was just literally last night was talking to an employee of ours and she said, 41:52 Speaker 3: dude, the Dihexa is awesome. She feels it right away and focus. 41:57 Speaker 3: And I thought that was interesting. It just just shows again, like the research that we do is like, 42:04 Speaker 3: you know, you can say 1 thing on paper. Yeah. But 42:07 Speaker 3: but actually, when people take it, oftentimes 42:10 Speaker 3: things are a bit different. 42:12 Speaker 0: I think that's cool. Now I do think it's again Chronic migraine, 15 or more headache days a month, each lasting 4 hours or more can make me feel like a spectator in my own life. Botox, onabotulinum 42:23 Speaker 1: toxin A, prevents headaches in adults with chronic migraine. It's not for those with 14 or fewer headache days a month. It's the number 1 prescribed branded chronic migraine preventive treatment. 42:33 Speaker 2: Prescription Botox is injected by your doctor. Effects of Botox may spread hours to weeks after injection, causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems, or muscle weakness can be signs of a life threatening condition. Patients with these conditions before injection are at highest risk. Side effects may include allergic reactions, neck and injection site pain, fatigue, and headache. Allergic reactions can include rash, welts, asthma symptoms, and dizziness. Don't receive Botox if there's a skin infection. Tell your doctor your medical history, muscle or nerve conditions, including ALS Lou Gehrig's disease, myasthenia gravis or Lambert Eaton syndrome, and medications, including botulinum toxins, as these may increase the risk of serious side effects. 43:09 Speaker 0: Why wait? Ask your doctor, visit botoxchronicmigraine.com, 43:12 Speaker 0: or call one-eight hundred-44Botox 43:14 Speaker 3: to learn more. Things where it may not work for me that great because I take too many stimulants. Right? I'm drinking coffee too much. There's too much thing too many things that are actually overpowering 43:24 Speaker 3: it. But 43:26 Speaker 3: like her, she was very clear. Like, she's clear and isn't taking much at all, just adding Dihexa and damn, she said she notices a lot. 43:35 Speaker 4: Is a great question. I've dealt with this a few times. So 43:39 Speaker 4: I like to pair Dihexa with a couple of other peptides. Right? So if it's someone that goes, hey. So I'll give you guys an example. 43:47 Speaker 4: There was a patient years ago when I was when I was, at a different telehealth company that he was going through med, 43:55 Speaker 4: law school, I believe is what it was. He was in law school. And he's like, Paul, he goes, I I don't wanna take Adderall. I really wanna take something that's gonna be natural, something that's a peptide. What can I do? 44:06 Speaker 4: So for him, what we did was we did 30 mg 44:09 Speaker 4: of Dihexa daily, 44:11 Speaker 4: and then we paired it with either I think we started them off at 0.5 a milligram of Tesofensine and worked our way up to a full milligram of Tesofensine. 44:18 Speaker 4: You put those 2 things together, 44:20 Speaker 4: that's just fireworks going off in your brain. And you you're able to 44:25 Speaker 4: not only focus, but you're able to pay attention. And also the best way they can explain is you can move from task to task very easily 44:32 Speaker 4: without 44:33 Speaker 4: slowing yourself down. So Tesofensine 44:36 Speaker 4: being that it's it's what we would call like a natural SSRI 44:40 Speaker 4: kinda gives you an overall sense of well-being. You feel happier. But what it's really doing to give you a great kick of energy 44:46 Speaker 4: is it's raising your basal metabolic rate, which is your your your rate at rest. Right? So it brings that up by about 5 to 10%. 44:54 Speaker 4: And Sure. 44:55 Speaker 4: It's a great appetite suppressant. So, also, that's just a kind of a pro tip for anybody that's getting off of a GLP 1 that's a little bit nervous about, hey, I don't wanna put on, you know, weight again. Bring in Tesofensine. 45:05 Speaker 4: And when you pair it with Dihexa, 45:07 Speaker 4: that's incredible. That's quite frankly, guys, full disclosure, that's how I've gotten through so many seminars. Let me tell you. All these seminars and conferences I've been to is, yeah, the Dihexa and Tesofensine. 45:17 Speaker 4: And then, 45:18 Speaker 4: to your point, Will, and I know we've we've talked about this before, when I'm presenting and when I'm actually speaking, 45:24 Speaker 4: for for doctors that receive their continuing education credits on peptides, 45:28 Speaker 4: that's where my nerves kick in. Right? 45:31 Speaker 4: Because as you guys said, none of us here are are MDs or DOs. Right? So the thing is is that I will always cite all of my work, do the clinical research, show the peer reviewed medical studies. 45:42 Speaker 4: And as I'm going through that, when I'm on stage talking to a group of, like, a 100 doctors, you know, nerves start to kick in a little bit. So what do I do in that in that regard? Was, well, I like to pair Selank, 45:52 Speaker 4: which is an antianxiety 45:53 Speaker 4: peptide with Dahexa. Keep me focused, make me feel like right where my feet are at. And that, that that's a really great combination, but Dahexa is fantastic. So 46:03 Speaker 4: the reason why Dahexa is a really incredible 46:06 Speaker 4: peptide is because they're studying it for Parkinson's, for Alzheimer's, for dementia. And I've actually seen the effects on on a 46:14 Speaker 4: person with dementia, a really good friend of mine. His father was 81 years old. He since passed. 46:19 Speaker 4: But before he passed a good, year or 2, 46:23 Speaker 4: before that, we 46:24 Speaker 4: actually had him on on quite a few peptides and brought him back from dementia. 46:29 Speaker 4: And he was actually 46:30 Speaker 4: yeah. It was incredible, man. We we did a lot of things for him. Huge. Yeah. What was the dosage? What was the daily dose orally that you guys At 30 I gave milligrams. And that's and just so that you guys know, 46:42 Speaker 4: before these peptides went on the do not compound list, 46:45 Speaker 4: because you gotta remember, since since my days in in all of the the telehealth companies that I've been at, so there's something called the SOAP notes, subjective assessment 46:54 Speaker 4: plans, right? That's what the doctors write in every chart for a patient. 46:59 Speaker 4: So within those SOAP notes, what's going to be in there is dosing, timing, frequency. So the dosing, timing, frequency that I'm always speaking about is actually what was clinically 47:08 Speaker 4: recommended and prescribed 47:10 Speaker 4: at the level of telehealth for these peptides before they went on the do not compound list. So what were we talking about for Dihexa back then? 20 to 30 mg a day. For how long? We 47:21 Speaker 4: would prescribe everything in 4 month increments. Every peptide I'm always going recommend 16 weeks. 47:26 Speaker 4: Yep. Okay. Got it. 47:27 Speaker 2: Nice man. 47:29 Speaker 2: Oh, I got last question. So I was just curious. And 47:33 Speaker 2: you kind of answered it, but I want to kind of still ask it. 47:36 Speaker 2: You know, there's still people that, you know, are so, 47:40 Speaker 2: so don't 47:42 Speaker 2: know anything about peptides and they compare them to steroids and all that stuff. Right? 47:47 Speaker 2: How far away, and you kind of answered it with FLGR, 47:50 Speaker 2: but how 47:51 Speaker 2: far away do you think science is of 47:54 Speaker 2: getting 47:56 Speaker 2: peptides into the degree where they somewhat 47:59 Speaker 2: compete with like some Anovar or smaller steroids 48:04 Speaker 2: that 48:05 Speaker 2: are going to give you some bulk? Mean, you know, IGF-one, I mean, there's a, know, you know what I mean? But like, we're so far away from like gear that like, 48:13 Speaker 2: do you think that's gonna happen, I guess, is the 1st question. 2nd is, if so, 48:18 Speaker 2: when roughly? 48:19 Speaker 4: So, 48:21 Speaker 4: again, you guys I love the questions. I was just about to say a great question. I'm I'm like a broken record every time you guys ask me something, but that was a great question. So the thing is is that 48:31 Speaker 4: there's variations of what we can do with peptides that are gonna be much safer than what we can do with hormones. 48:37 Speaker 4: Right? So 48:39 Speaker 4: so I'll give you guys, an example because and to answer your question, we already are kind of competing a little bit in in that regard when it comes to peptides and hormones. 48:48 Speaker 4: But hormones are are different in the sense that they're controlling 48:52 Speaker 4: the entire body, right, to where the peptide is controlling a specific mechanism, and it's actually getting the body to perform naturally the way that it wants. So they're just signaling molecules. But I'll give you guys an example because remember, also my background 49:06 Speaker 4: is in is also from sports supplements and bodybuilding years ago, right, when I was head of marketing for a really big 49:13 Speaker 4: supplement company. 49:14 Speaker 4: So 49:15 Speaker 4: 1 of the things that bodybuilders really love is growth hormone paired with insulin. 49:21 Speaker 4: Right? That's a big 1 because that's going to put a lot of size on you, a lot of mass on you. It's going to get you going. It's going raise your IGF levels. 49:27 Speaker 4: So but it's raising your IGF levels exogenously from outside the body, right, not in a natural way the way that a growth hormone releasing peptide will. Well, what's the peptide equivalent 49:37 Speaker 4: of GH and SLN? Well, the peptide equivalent that I've actually seen work very well would be MK-six 77, which is ibutamoren 49:44 Speaker 4: and IGF LR3. 49:46 Speaker 4: Because ibutamorin is gonna kick up your IGF levels, it's gonna make you hungrier, produce more ghrelin, which is a hormone that that's telling you you're hungry. And then you pair that with IGF LR3, so it's shuttling the nutrients and and food to the muscles that you're breaking down. 49:59 Speaker 4: The equivalent right there. Now, is it exactly the same? Absolutely not. Does it work in the same regard using the same mechanism of actions? Yes, it does. It's pretty incredible. Do 50:09 Speaker 4: I think that we'll eventually get to a point toward these that the peptides can 50:14 Speaker 4: do exactly what the hormones do? 50:16 Speaker 4: I don't know. 50:18 Speaker 4: That's a great question. Don't know if we'll get there. I don't know if we wanna get there because we we can always use the replacement therapies of the hormones to do that. But what we are doing with peptides is getting the body to perform naturally the way that it wants to by kicking on its own growth hormone release, whatever it is that we're doing. So like Kisspeptin is bringing up the testosterone, 50:37 Speaker 2: things of that nature. But yeah, I love that question. Yeah, I'm sorry. Last 1, because now just, I'm actually curious. 50:43 Speaker 2: So we get a lot of questions 50:46 Speaker 2: about 50:47 Speaker 2: high school kids. Okay. And now peptides are so big that, 50:52 Speaker 2: you know, we have a lot of parents ask us about our opinions on like growth hormones, cretagogues and whatnot. 50:59 Speaker 2: Without And me, us telling you our answer, 51:01 Speaker 2: what is your take on that? You have a high school dad that his kid has a great arm and he wants to go, he's going pro, my kid's going pro, you know, like every father thing. And he's 12. Yeah, 51:13 Speaker 2: right. But let's at least say teens, 15. Let's say 15. 15, 16. 51:18 Speaker 4: What would you say? What's your opinion on that? I've actually dealt with that exact scenario that you just gave me. Baseball. I've dealt with the baseball bat. Yep. I dealt with that while I was at 51:28 Speaker 4: the the largest telehealth, 51:30 Speaker 4: company 51:31 Speaker 4: in in the country, right, years ago. You're going back maybe, like, 5 years ago, something like that. 51:37 Speaker 4: So so the so I'll always because, again, I gotta deal with attorneys all the time. So we're gonna go with the legal answer is anyone who's under 21 years old, you can't recommend okay. Now let's talk about if it was my kid. So let's make it personal. Right? Perfect. That's how we do Let's talk about my kid. 51:52 Speaker 4: Now that's going to be at the discretion of the parent of now the the kid that I'm talking about, he was 17 years old, so he was kinda like right there at that cusp of being 18 and getting in that range. And the dad was like, hey, man. I'm ordering CJC for myself. 52:07 Speaker 4: And I if I wanna give this to my kid, what do you think? I go, well, look, man. Your kid's already making enough growth hormone as it is. I don't see that something that you should be doing, but you're his father. That's up to you. It's whatever you But wanna 52:21 Speaker 4: let's take it a step further, guys, 52:24 Speaker 4: that if it was my kid and he got injured. Let me talk about that. Yeah. Okay. So if he got he or she, God forbid, got injured. Because I have dealt with this. 52:33 Speaker 4: Folks will ask me this all the time. Hey. You know what? My kid's knee, ACL, MCL, their labrum, whatever it was. Again, not legal or medical advice, but if it was my own kid and they're 16, 17, 8, whatever it is, would I give them BPC? 52:48 Speaker 4: Would I give them TB-five hundred? There's no question in my mind that I absolutely would. A 100%. 52:54 Speaker 2: You answered it to the T how we have answered it. That's great. 52:59 Speaker 2: Either of my sons, I would give them the Wolverine. 53:02 Speaker 2: To this day, my brother, I have, I have, I have thrown out your protocol 53:07 Speaker 2: because everybody in the like that's watches knows that I have had back surgery. They're always asking man. I'm glad to help you. I hope afford a 53:15 Speaker 4: lot, take a lot because it worked well. Was in the gym 2 weeks later and lifting. I love it, man. That's what it's about being able to help everyone out there, man. I appreciate that. But yeah, girl, my dog, I give my dog 1 more time. Yeah, no doubt. 53:29 Speaker 3: My dog also. So I gave my dog a lot of, TB 500 53:34 Speaker 3: and I should have given him more 53:38 Speaker 3: anti cancer 53:39 Speaker 3: because that's what killed him. 53:41 Speaker 3: That's inevitably, 53:42 Speaker 3: you know, you've met my dog, Oscar. He was big. He 53:46 Speaker 2: was great. 53:47 Speaker 3: Still running up trees. He was about a 100 pound like Pitbull Rottweiler mix and had a seizure on a Sunday night. By next, by the following Thursday, I put him down and apparently he had cancer in his stomach, 54:00 Speaker 3: lungs, 54:01 Speaker 3: and then brain, which is what caused the seizure. But TB-five hundred, a lot of the, a lot of the tests, you know, the, the research actual like R and D and TB-five hundred is, is on canines. 54:11 Speaker 3: So for his, he tore both his ACLs at 1 point, but 1 of them, I didn't have surgery. I just threatened him like, dude, you need to heal this leg or I might were cutting it off. But I did this $6,000 54:21 Speaker 3: surgery for the 1st knee and then he tore the 2nd 1, but I never did anything. Gave him, I gave him some TB 500, 54:29 Speaker 3: man. He healed and never like limped. Was never bow legged. You see a lot of dogs who 54:35 Speaker 3: they tore their ACLs and no surgery and they're kind of walking bow legged now or limping. I mean, he got old 12, 13 years old and just never even had any leg problems, even tearing both these heels. 54:46 Speaker 4: It definitely works, man. And you know what? A good friend of mine, you guys also know Trevor, he he recently, 54:51 Speaker 4: adopted a Saint Bernard, and he thought that the Saint Bernard's hip was was off. He didn't know what was going on, like it had hip dysplasia. 54:58 Speaker 4: Well, he started giving his dog BPC, 55:00 Speaker 4: and now he's running up on tables. He can do anything he needs to do. It's it's it's pretty incredible. And also, Will, to your point, you know, 1 of the things that that I will always mention to folks, you know, battling the big c word, right, is 55:15 Speaker 4: let me say this. In 50 countries around the world, thymosin alpha-one is used in oncology. 55:23 Speaker 4: So do with that information what you want audience, but do some research on that. I just want you guys to at least be aware of that because that's a big 1. And some of the oncologists, the more forward thinking ones, especially actually in California, 55:35 Speaker 4: they are starting to incorporate Thymosin Alpha-one in their treatments. That stuff's amazing. I love it. I 55:42 Speaker 3: forget the name of the actual drug, the pharmaceutical drug that it is, that it's under. But yes, in all these different countries, we did 1, we did peptide 55:51 Speaker 3: of the week on Thymosin Alpha somewhat recently. Love it. Love it. 55:56 Speaker 2: Mean- Right on dude. Well, yeah, man, we love you brother. I mean, we could talk forever. Have multiple questions, but we have, we obviously 56:03 Speaker 2: will have you on. We'd love you to get in here next time. Next time you got my word up, I'll be in there. I'll come down the road. We've done in the studio that we have you on the screen. So as you listeners and people on Spotify and YouTube are watching, we might be looking a little weird in different directions because it was our 1st time we'll get that dialed in because he will not be the 1st that we do this with. We're just used to sitting, talking to each other, but we'll get a hologram. We're going to get a hologram of you sitting 56:29 Speaker 3: there. 56:30 Speaker 2: High 5 56:30 Speaker 2: week. 56:32 Speaker 2: Get the AI do version of it. That'll work great, man. We love you, man. I love your stuff too. I watch it all the time, man. The Jedi. So tell everybody as we close out, where can they find you? Thank you. You, it's just my name at Paul Bakhtior and Bakhtior is b a k h t I a r across all socials, guys. Thank you so much. 56:53 Speaker 3: Awesome, man. We're gonna get you, Paul, to respond, 56:58 Speaker 3: give us some a little bit of input in our elite, 57:01 Speaker 3: in our, like, warrior elite 57:03 Speaker 3: new platform, which you don't really know anything about it, but we're going to get you some people who are part of that. We'll get Paul to pop in there every once in a while. Yeah. We will alert people that we do want to talk about that before I forgot. 57:16 Speaker 2: We have just dropped the Warrior 57:19 Speaker 2: platform. 57:21 Speaker 2: We got tired of getting 57:23 Speaker 2: shadow banned. We got tired of getting things taken down. We got tired of big brother's easiest way to say it. So we built our own platform and we released it 2 days ago and it's exceeded our expectations by a We're blown away by how many people are joining and people are not just joining, they're posting, 57:38 Speaker 2: they're lifting each other up. They are talking. Oh man, it is just a raddest community. 57:43 Speaker 2: So join it. We're gonna put the links all over, shoot us DMs, we'll get you in, but get in and you're gonna have access to us, guys like Paul and a lot of other stuff that we can't say on social media, so you wanna do it. So 57:57 Speaker 2: that is it for the day, my friends, and we will catch you next time. 58:01 Speaker 4: Thank you, guys.